VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 356 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2016. The put-call ratio across all filers is 1.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $5,310,000 | -23.5% | 481,390 | +0.7% | 0.82% | -23.3% |
| Q4 2016 | $6,942,000 | -18.6% | 478,125 | +37.6% | 1.07% | -14.7% |
| Q3 2016 | $8,528,000 | +37.4% | 347,368 | +12.7% | 1.26% | +38.2% |
| Q2 2016 | $6,206,000 | -31.2% | 308,142 | -10.1% | 0.91% | -19.9% |
| Q1 2016 | $9,019,000 | -73.6% | 342,916 | +2.0% | 1.13% | -73.4% |
| Q4 2015 | $34,186,000 | -35.5% | 336,306 | +13.3% | 4.26% | -32.4% |
| Q3 2015 | $52,967,000 | -21.2% | 296,931 | -1.9% | 6.30% | -11.9% |
| Q2 2015 | $67,248,000 | +14.6% | 302,715 | +2.5% | 7.16% | +5.9% |
| Q1 2015 | $58,656,000 | +40.0% | 295,320 | +0.9% | 6.76% | +46.7% |
| Q4 2014 | $41,903,000 | +7.6% | 292,802 | -1.4% | 4.61% | -0.1% |
| Q3 2014 | $38,949,000 | +2.8% | 296,871 | -1.2% | 4.61% | +6.3% |
| Q2 2014 | $37,892,000 | -5.3% | 300,446 | -1.0% | 4.34% | -14.2% |
| Q1 2014 | $40,015,000 | -7.9% | 303,536 | -17.9% | 5.05% | -6.2% |
| Q4 2013 | $43,426,000 | -26.8% | 369,896 | -34.9% | 5.39% | -1.0% |
| Q3 2013 | $59,294,000 | – | 568,332 | – | 5.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |